ESC Premium Access

Predictive value of macrophage migration inhibitory factor (MIF) in heart failure with preserved ejection fraction (HFpEF)

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Peter Ludike

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)
0 follower

21 more presentations in this session

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Thumbnail

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Speaker: Doctor K. Kopeva (Tomsk, RU)

Thumbnail

Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Speaker: Doctor Q. Wang (Lanzhou, CN)

Thumbnail

Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity

Speaker: Associate Professor M. Marketou (Heraklion, GR)

Thumbnail

Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.

Speaker: Doctor M. Kurkina (Moscow, RU)

Thumbnail

Access the full session

Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Doctor P. Ludike, Associate Professor H. Fukuta, Doctor K. Kopeva, Doctor Q. Wang, Associate Professor M. Marketou...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb